ID22753A - Turunan-turunan benzotiofenkarboksamida dan antagonis pgd2 yang mengandung turunan benzotiofenkarboksamida tersebut - Google Patents

Turunan-turunan benzotiofenkarboksamida dan antagonis pgd2 yang mengandung turunan benzotiofenkarboksamida tersebut

Info

Publication number
ID22753A
ID22753A IDW990472A ID990472A ID22753A ID 22753 A ID22753 A ID 22753A ID W990472 A IDW990472 A ID W990472A ID 990472 A ID990472 A ID 990472A ID 22753 A ID22753 A ID 22753A
Authority
ID
Indonesia
Prior art keywords
benzotiofencarcoxamide
benzotiofencarcox
carboxamide
characters
distribution
Prior art date
Application number
IDW990472A
Other languages
English (en)
Indonesian (id)
Inventor
Tsunetoshi Honbma
Yoshiharu Hiramatsu
Akinori Arimura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of ID22753A publication Critical patent/ID22753A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
IDW990472A 1996-12-13 1997-12-10 Turunan-turunan benzotiofenkarboksamida dan antagonis pgd2 yang mengandung turunan benzotiofenkarboksamida tersebut ID22753A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33349596 1996-12-13
JP25400197 1997-09-19

Publications (1)

Publication Number Publication Date
ID22753A true ID22753A (id) 1999-12-09

Family

ID=26541496

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990472A ID22753A (id) 1996-12-13 1997-12-10 Turunan-turunan benzotiofenkarboksamida dan antagonis pgd2 yang mengandung turunan benzotiofenkarboksamida tersebut

Country Status (25)

Country Link
US (1) US6083974A (fr)
EP (1) EP0944614B1 (fr)
JP (1) JP3215441B2 (fr)
KR (1) KR100433568B1 (fr)
CN (2) CN1105112C (fr)
AR (1) AR008939A1 (fr)
AT (1) ATE223911T1 (fr)
AU (1) AU718958B2 (fr)
BR (1) BR9714016A (fr)
CA (1) CA2274591C (fr)
CZ (1) CZ297324B6 (fr)
DE (1) DE69715448T2 (fr)
DK (1) DK0944614T3 (fr)
ES (1) ES2181039T3 (fr)
HU (1) HU226458B1 (fr)
ID (1) ID22753A (fr)
IL (1) IL130660A (fr)
NO (1) NO992838L (fr)
NZ (1) NZ336143A (fr)
PL (1) PL191760B1 (fr)
PT (1) PT944614E (fr)
RU (1) RU2161617C1 (fr)
TR (1) TR199901280T2 (fr)
TW (1) TW438790B (fr)
WO (1) WO1998025919A1 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL343316A1 (en) 1998-03-31 2001-08-13 Shionogi & Co Process for producing 5-hydroxybenzo[b]thiophene-3-carboxylic acid derivatives
CN1138772C (zh) 1998-03-31 2004-02-18 盐野义制药株式会社 苯并噻吩羧酸酰胺衍生物的制备方法
KR100422920B1 (ko) * 1998-06-03 2004-03-12 시오노기세이야쿠가부시키가이샤 Ｐｇｄ2 길항제를 포함하는 소양증을 위한 치료제
AU5430100A (en) * 1999-07-02 2001-01-22 Shionogi & Co., Ltd. Novel process for producing bicyclic amino alcohol
US6743793B2 (en) 2000-03-09 2004-06-01 Ono Pharmaceutical Co., Ltd. Indole derivatives, process for preparation of the same and use thereof
ATE311200T1 (de) * 2000-04-12 2005-12-15 Merck Frosst Canada Inc Verfahren und zusammensetzungen zur behandlung von allergischen zuständen mit pgd2 rezeptor antagonisten
US6410583B1 (en) * 2000-07-25 2002-06-25 Merck Frosst Canada & Co. Cyclopentanoindoles, compositions containing such compounds and methods of treatment
US7273883B2 (en) 2000-09-14 2007-09-25 Allergan, Inc. Prostaglandin EP4 antagonist
US7217725B2 (en) 2000-09-14 2007-05-15 Allergan, Inc. Prostaglandin D2 antagonist
DE60108515T2 (de) 2000-10-17 2006-01-12 Shionogi & Co., Ltd. Verfahren zur herstellung eines pgd2-antagonisten
EP1338594A4 (fr) * 2000-11-01 2004-06-16 Shionogi & Co Compositions pharmaceutiques antagonistes du recepteur de pgd2
AR038136A1 (es) 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
MXPA04009095A (es) * 2002-03-19 2004-12-06 Ono Pharmaceutical Co Compuesto de acido carboxilico y agente farmaceutico que comprende el compuesto como ingrediente activo.
JPWO2004006956A1 (ja) * 2002-07-12 2005-11-10 独立行政法人科学技術振興機構 脳損傷の予後改善薬とそのスクリーニング方法
JPWO2004030674A1 (ja) * 2002-09-30 2006-01-26 塩野義製薬株式会社 プロスタグランジンｄ▲下２▼、プロスタグランジンｄ▲下２▼アゴニストおよびプロスタグランジンｄ▲下２▼アンタゴニストの新規用途
BR0315681A (pt) 2002-10-30 2005-09-06 Merck Frosst Canada Inc Composto e seus sais e hidratos farmaceuticamente aceitáveis, composição farmacêutica, métodos para o tratamento de doenças mediadas pela prostaglandina d2, para o tratamento de congestão nasal, para o tratamento de asma alérgica, e para o tratamento de rinite alérgica, composto ou um seu sal ou solvato farmaceuticamente aceitável, sal ou hidrato do composto, e, uso de um composto ou de um seu sal ou solvato farmaceuticamente aceitável
US7714132B2 (en) 2004-03-11 2010-05-11 Actelion Pharmaceuticals, Ltd. Tetrahydropyridoindole derivatives
WO2006068162A1 (fr) * 2004-12-24 2006-06-29 Shionogi & Co., Ltd. Agent thérapeutique pour le traitement de la bronchopneumopathie chronique obstructive
TW200716093A (en) * 2005-04-28 2007-05-01 Shionogi & Co An antiasthmatic agent containing PGD2 receptor antagonist and leukotriene receptor antagonist
TWI410410B (zh) 2007-08-10 2013-10-01 Ono Pharmaceutical Co Phenylacetic acid compounds
US8674115B2 (en) 2009-12-23 2014-03-18 Ironwood Pharmaceuticals, Inc. CRTH2 modulators
US20130178475A1 (en) 2010-03-17 2013-07-11 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
WO2012003405A1 (fr) 2010-06-30 2012-01-05 Ironwood Pharmaceuticals, Inc. Stimulateurs de sgc
WO2012009137A1 (fr) 2010-07-12 2012-01-19 Ironwood Pharmaceuticals, Inc. Modulateurs de crth2
US20130259830A1 (en) 2010-07-12 2013-10-03 Ironwood Pharmaceuticals, Inc. Crth2 modulators
NZ609955A (en) 2010-11-09 2015-05-29 Ironwood Pharmaceuticals Inc Sgc stimulators
CN104066731B (zh) 2011-12-27 2016-06-15 铁木医药有限公司 可用作sgc刺激剂的2-苄基、3-(嘧啶-2-基)取代的吡唑类
US9309235B2 (en) 2012-09-18 2016-04-12 Ironwood Pharmaceuticals, Inc. SGC stimulators
US9487508B2 (en) 2012-09-19 2016-11-08 Ironwood Pharmaceuticals, Inc. SGC stimulators
SI2970243T1 (sl) 2013-03-15 2020-04-30 Cyclerion Therapeutics, Inc. SGC stimulatorji
EP3092231B1 (fr) 2013-12-11 2018-06-27 Ironwood Pharmaceuticals, Inc. Stimulateurs de la sgc
EP3094327A1 (fr) 2014-01-13 2016-11-23 Ironwood Pharmaceuticals, Inc. Utilisation de stimulateurs de la sgc pour le traitement de troubles neuromusculaires
US20170298055A1 (en) 2014-09-17 2017-10-19 Ironwood Pharmaceuticals, Inc. sGC STIMULATORS
CA2959757A1 (fr) 2014-09-17 2016-03-24 Ironwood Pharmaceuticals, Inc. Derives de pyrazole utilises comme stimulateurs de sgc
CA2961489A1 (fr) 2014-09-17 2016-03-24 Glen Robert RENNIE Stimulateurs de sgc
WO2016128565A1 (fr) 2015-02-13 2016-08-18 Institut National De La Sante Et De La Recherche Medicale (Inserm) Antagonistes de ptgdr-1 et/ou de ptgdr-2 pour la prévention et/ou le traitement du lupus érythémateux systémique
KR102513343B1 (ko) 2016-07-07 2023-03-22 사이클리온 테라퓨틱스, 인크. sGC 자극제의 인 전구약물
BR112019000293A2 (pt) 2016-07-07 2019-04-16 Ironwood Pharmaceuticals, Inc. formas sólidas de um estimulador de sgc

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8406906D0 (en) * 1984-03-16 1984-04-18 Akzo Nv Benzo-thiazole and benzothiophene derivatives
US4560343A (en) * 1984-06-11 1985-12-24 Honeywell Inc. Functional check for a hot surface ignitor element
JPS6149A (ja) * 1984-06-12 1986-01-06 Ono Pharmaceut Co Ltd 新規な１３―アザ―１４―オキソ―ＴｘＡ２類似化合物およびそれらを有効成分として含有するトロンボキサン起因疾患治療剤
NZ218115A (en) * 1985-11-18 1990-02-26 Shionogi & Co Bicyclic sulphonamides and pharmaceutical compositions
CA1294974C (fr) * 1987-05-08 1992-01-28 Sanji Hagishita Derives de sulfonamide bicycliques et leur procede de preparation
US5356926A (en) * 1992-02-24 1994-10-18 Warner-Lambert Company 3-alkyloxy-, aryloxy-, or arylalkyloxy-benzo [β]thiophene-2-carboxamides as inhibitors of cell adhesion
CA2113787A1 (fr) * 1993-01-29 1994-07-30 Nobuyuki Hamanaka Sulfonamides carbocycliques
DE4317076A1 (de) * 1993-05-21 1994-11-24 Bayer Ag Benzthiophencarbonsäureamid-S-oxide
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
ATE337294T1 (de) * 1995-06-21 2006-09-15 Shionogi & Co Bizyklische aminoderivate und enthaltende pgd2- antagonisten
WO1998015545A1 (fr) * 1996-10-08 1998-04-16 Eli Lilly And Company Nouveaux agonistes de la serotonine 5-ht¿1f?

Also Published As

Publication number Publication date
BR9714016A (pt) 2000-02-29
RU2161617C1 (ru) 2001-01-10
CA2274591C (fr) 2005-06-14
EP0944614B1 (fr) 2002-09-11
CN1240438A (zh) 2000-01-05
US6083974A (en) 2000-07-04
DE69715448T2 (de) 2003-08-07
HUP0002869A3 (en) 2003-01-28
IL130660A0 (en) 2000-06-01
TR199901280T2 (xx) 1999-10-21
PT944614E (pt) 2003-01-31
CZ206599A3 (cs) 1999-11-17
ES2181039T3 (es) 2003-02-16
KR20000069402A (ko) 2000-11-25
DE69715448D1 (de) 2002-10-17
AU5409798A (en) 1998-07-03
AR008939A1 (es) 2000-02-23
TW438790B (en) 2001-06-07
JP3215441B2 (ja) 2001-10-09
KR100433568B1 (ko) 2004-05-31
NO992838D0 (no) 1999-06-10
PL191760B1 (pl) 2006-06-30
DK0944614T3 (da) 2003-01-13
HUP0002869A2 (hu) 2001-06-28
EP0944614A1 (fr) 1999-09-29
CA2274591A1 (fr) 1998-06-18
NZ336143A (en) 2002-05-31
JP2000514824A (ja) 2000-11-07
NO992838L (no) 1999-07-20
CZ297324B6 (cs) 2006-11-15
WO1998025919A1 (fr) 1998-06-18
AU718958B2 (en) 2000-05-04
ATE223911T1 (de) 2002-09-15
CN1445225A (zh) 2003-10-01
HU226458B1 (en) 2008-12-29
PL334072A1 (en) 2000-01-31
CN1105112C (zh) 2003-04-09
IL130660A (en) 2002-03-10
CN1185226C (zh) 2005-01-19
HK1020045A1 (en) 2000-03-10

Similar Documents

Publication Publication Date Title
ID19903A (id) Peralatan pendayagunaan alat dan metodanya
ID26099A (id) Turunan amida dan antagonis nosiseptin
DE69729805D1 (de) Vorrichtung und verfahren von thermischem spritzen mit übertragenem lichtbogen
IL130660A0 (en) Benzothiophenecarboxamide derivatives and PGD2 antagonists comprising them
ID24284A (id) Produk-produk absorben serta peralatan dan metode untuk memproduksi produk-produk absorben tersebut
ID22426A (id) Ketobenzamida yang baru dan penggunaannya
ID24623A (id) Peralatan dan metode pengisian serbuk
ID19422A (id) Piridina dan bifenil tersubstitusi
ID22807A (id) Hasil derifat 1-aril dan piridilpirazol untuk pestisida
PL337781A1 (en) Antagonists and reverse antagonists of glucogene
EG21581A (en) Stable web having enhanced extensibility and method of making
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
ID26104A (id) Metoda-metoda dan bahan-bahan untuk mengobati dan mencegah radang jaringan mukosa
ID21781A (id) Benzamidoaldehida baru dan penggunaannya
PL336213A1 (en) Gnrh antagonists modified at positions 5 and 6
ID18816A (id) Metode dan perangkat injeksi refrigran campuran
ID27544A (id) Agonis dan antagonis muskarinat
ID18456A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID18682A (id) Asiltransferase dan plasma yang mengkodekan asiltransferase
ID18459A (id) Produksi-bersama 6-aminokapronitril dan heksametilenadiamina
ID20771A (id) Produk yang dibusakan-injeksi dan metode pembuatannya
HU9700660D0 (en) Use of alpha-adrenoreceptor antagonists for profilacting and treating hyperplasia benigna prostatae
ID28296A (id) Jaringan berliang renik yang tahan robek dan dapat ditarik
ID16587A (id) Koproduksi 6-aminokapronitril dan heksametilendiamin
ID21847A (id) Komposisi insektisida dan metoda penggunaannya